Stoke Therapeutics, Inc.

STOK Nasdaq CIK: 0001623526

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 45 WIGGINS AVENUE, BEDFORD, MA, 01730
Mailing Address 45 WIGGINS AVENUE, BEDFORD, MA, 01730
Phone 781-430-8200
Fiscal Year End 1231
EIN 471144582

Financial Overview

FY2024

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 5, 2026 View on SEC
8-K Current report of material events January 26, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report December 10, 2025 View on SEC
4 Insider stock transaction report December 10, 2025 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC
8-K Current report of material events December 5, 2025 View on SEC
4 Insider stock transaction report December 5, 2025 View on SEC

Insider Trading

STRONG SELL 4 insiders 32 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.